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Abstract
microRNAs (miRNAs) are non-coding RNAs that regulate gene expression post-transcriptionally, and mounting evidence
supports the prevalence and functional significance of their interplay with transcription factors (TFs). Here we describe the
identification of a regulatory circuit between muscle miRNAs (miR-1, miR-133 and miR-206) and Yin Yang 1 (YY1), an
epigenetic repressor of skeletal myogenesis in mouse. Genome-wide identification of potential down-stream targets of YY1
by combining computational prediction with expression profiling data reveals a large number of putative miRNA targets of
YY1 during skeletal myoblasts differentiation into myotubes with muscle miRs ranking on top of the list. The subsequent
experimental results demonstrate that YY1 indeed represses muscle miRs expression in myoblasts and the repression is
mediated through multiple enhancers and recruitment of Polycomb complex to several YY1 binding sites. YY1 regulating
miR-1 is functionally important for both C2C12 myogenic differentiation and injury-induced muscle regeneration.
Furthermore, we demonstrate that miR-1 in turn targets YY1, thus forming a negative feedback loop. Together, these results
identify a novel regulatory circuit required for skeletal myogenesis and reinforce the idea that regulatory circuitries involving
miRNAs and TFs are prevalent mechanisms.
Citation: Lu L, Zhou L, Chen EZ, Sun K, Jiang P, et al. (2012) A Novel YY1-miR-1 Regulatory Circuit in Skeletal Myogenesis Revealed by Genome-Wide Prediction of
YY1-miRNA Network. PLoS ONE 7(2): e27596. doi:10.1371/journal.pone.0027596
Editor: Andre Van Wijnen, University of Massachusetts Medical, United States of America
Received June 15, 2011; Accepted October 20, 2011; Published February 1, 2012
Copyright:  2012 Lu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The work described in this paper was substantially supported by three General Research Funds (GRF) to H.W. and H.S. from the Research Grants Council
(RGC) of the Hong Kong Special Administrative Region, China (Project Code: 2140655, 2140701 and 473211), a CUHK Direct Grant to H.W. (2041474) and a CUHK
Direct Grant to H. S. (2041492). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: huating.wang@cuhk.edu.hk (HW); haosun@cuhk.edu.hk (HS)
Introduction
microRNAs (miRNAs) are non-coding single-stranded RNAs of
21 to 25 nucleotides and constitute a novel class of gene regulators
that are found in many eukaryotic organisms. miRNAs negatively
regulate their targets at the post-transcriptional level through
binding to their 39 UTR regions leading to either mRNA cleavage
or translational repression depending on the degree of comple-
mentarities between the miRNA and the target [1]. In recent
years, growing body of evidence supports the involvement of
miRNAs as widespread regulators in a variety of biological
processes as well as their roles in diverse pathologies. Of particular
interest, mounting reports have demonstrated the regulatory roles
of miRNAs in muscle development and muscle related diseases
[2,3,4,5,6].
Skeletal muscle growth and regeneration are attributed to
satellite cells-muscle stems cells, which are characterized by the
expression of paired-box transcription factor 7 (Pax7) and when
activated, become immature muscle cells or myoblasts which will
proliferate and differentiate. The formation of mature muscle
proceeds with the exit of myoblasts from the cell cycle, the
expression of muscle-specific genes and the suppression of genes
that are specific to other cell lineages and tissues [7]. A major
portion of our understanding of myogenic differentiation is focused
at the level of transcription, orchestrated by a complex network of
transcription factors (TFs) including MyoD, Myogenic Factor 5
(Myf5), Myogenin, Myogenic Regulatory Factor 4 (MRF4), and
myocyte enhancer factor 2 (Mef2). These factors activate muscle
specific genes to coordinate myoblasts to terminally withdraw from
the cell cycle and subsequently fuse into multinucleated myotubes
[8]. Pax7, on the other hand, is required for satellite cell
proliferation and sustained expression of Pax7 prevents myogenic
induction and muscle terminal differentiation [9].
Studies from recent years have incorporated miRNAs into the
complex network of regulation. A subset of these miRNAs, miR-1,
miR-133, and miR-206, are muscle specific and have been the
focus of intensive investigation [5]. For instance, MyoD and Mef2
regulate the expression of miR-1 that suppresses Histone
Deacetylase 4 (HDAC4), resulting in augmented Mef2 activity
[10,11]. MyoD also induces miR-206 which targets DNA
polymerase alpha to facilitate cell cycle exit and follistatin to
presumably enhance myogenesis [12,13,14]. In contrast, synthesis
of miR-133 inhibits myogenesis through the down-regulation of
serum response factor (SRF) which maintains myoblasts in a
proliferative state [15]. Thus miR-1, miR-133 and miR-206 play
central regulatory roles in muscle biology and are called muscle
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also support the involvement of non-muscle miRs in myogenesis.
For example, Juan et al characterized a double-negative feedback
loop comprising of miR-214 and a histone methyltransferase Ezh2
recently [16]. These studies clearly demonstrate the crucial roles of
TF-miRNA circuitries in regulating gene expression. However, in
myogenesis, the total number of miRNA genes reported to form
the regulatory circuitries only accounts for ,2% of all mouse
miRNAs found in miRBase [17]. And the regulatory mechanisms
of the majority miRNAs in myogenesis are still largely unknown.
In an effort to elucidate the transcriptional and post-transcrip-
tional regulation during skeletal myogenesis, we identified an NF-
KappaB (NF-kB)-Yin Yang1 (YY1)-miR-29 signaling axis. YY1, a
ubiquitously expressed transcription factor, upon activation by
NF-kB signaling, functions to repress muscle differentiation by
epigenetically silencing the transcription of miR-29 expression
through recruiting histone methyltransferase Ezh2 containing
Polycomb complex as well as histone deacetylase 1(HDAC1)
[18,19]. At the onset of myogenesis, YY1 is down-regulated by
decreased NF-kB signaling, which results in the replacement of
YY1/Ezh2/HDAC1 repressive complex by an activator complex
containing MyoD, serum response factor (SRF) along with
associated acetyltransferases CBP and p300/CBP-associated
factor (PCAF), leading to the activation of miR-29 [18,20]. Our
findings together with others’ [20] highlight the essential roles of
YY1 in the epigenetic regulation of myogenesis. Considering the
prevalence of YY1 binding sites in the genome (,70% of
vertebrate genes and ,24% of viral genes contained YY1 binding
elements [21]), we speculate that many other miRNAs could come
under regulation by YY1, forming numerous functional regulatory
circuitries.
In this study we perform genome-wide identification of YY1
targeted miRNAs by combining computational prediction and
expression profiling data. We further demonstrate that muscle
miRs are regulated by YY1 and elucidate its underlying
mechanism as well as functional significance both in vitro using
C2C12 mouse muscle cells and in vivo using cardiotoxin induced
muscle regeneration model.
Results
Computational prediction reveals the prevalence of YY1
binding sites in miRNA promoter regions
In order to identify novel YY1-miRNA regulatory circuits and
gain insights into the magnitude of the number of YY1 regulated
miRNAs, we developed a bioinformatics pipeline, mainly based on
ab initio sequence analysis. The major limitation in studying
transcriptional regulation of miRNA genes has been sparse
annotation of miRNA gene transcriptional start sites (TSSs) and
promoter regions. Marson et al. took advantage of genome-wide
mapping of trimethylation of histone H3 lysine 4 mark, which
associates with TSSs of most genes, to systematically identify the
promoter regions for over 80% of miRNAs in both mouse and
human [22]. The annotation of 185 murine primary microRNA
(pri-miRNA) transcripts specifying 336 mature miRNA was
retrieved from this study. We further reasoned that histone mark
based annotation is only a coarse estimation of promoter location,
we thus decided to refine it using a promoter prediction program
EP3 [23]. This is a tool for identification of the core promoter of a
eukaryotic gene by using GC content and large-scale structural
features of DNA. When evaluated on 12 eukaryotic genomes, EP3
demonstrated high performance. Subsequently, we applied EP3
on the above 185 mouse pri-miRNA transcripts to obtain the
refined promoters for these miRNAs; the refined promoter regions
were then extended by 15 kbp on both sides and subjected to YY1
binding sites search. Four YY1 positional weight matrices were
retrieved from Transfac database [24] and used to scan for YY1
sites with STORM program [25] (Suppl. Table S1). Furthermore,
we reasoned that functional YY1 regulation on miRNA genes
should lead to silencing of their expression in myoblasts and up-
regulation of miRNA expression levels upon myoblasts differen-
tiation as YY1 is known as a repressor of muscle genes and YY1
itself is gradually down-regulated in myogenic differentiation [19].
We thus performed a microarray study to identify differentially
expressed miRNAs during myogenic differentiation of mouse
C2C12 myoblast cells. Total RNAs were isolated from undiffer-
entiated C2C12 myoblasts in growth medium (GM) or myotubes
formed in differentiation medium (DM) for 1 or 3 days and
subjected to miRNA array analyses using microRNA CHIPv4
[26]. Although miRNA profiling during C2C12 differentiation has
been conducted by Wong C.F. et al [27], our array platform
contains a larger number of mouse miRNAs (373 vs 208). As a
result, we found that 77 and 68 miRNAs in DM were up- and
down-regulated more than two folds as compared with GM
(Suppl. Table S2 and S3). This is significantly more than what was
found by Wong C.F. (5 up-regulated and 1 down-regulated). By
running the 77 up-regulated miRNA genes through YY1 binding
site search pipeline described earlier, we were able to identify 30
miRNAs with at least one YY1 binding site on their promoters
(Table 1). Interestingly, YY1 bindings sites were also frequently
found on the promoters of miRNAs with high expression levels in
myoblasts but down-regulated during differentiation (Suppl. Table
S4), suggesting that YY1 can also function as a potential activator
for these miRNAs to maintain their expression in myoblasts. To
visualize the level of YY1 binding site enrichment, we ranked
miRNAs according to their expression levels during differentiation
so that the up-regulated and down-regulated miRNAs were
grouped to the top and bottom of the panel, respectively and the
unchanged ones located in the middle portion (Fig. 1A). The YY1
binding frequency in a sliding window from the up- to down-
regulated genes was then calculated using a method described by
Fei T [28]. It was found that YY1 binding sites were over-
represented in both up- and down-regulated miRNAs but not in
those without significant changes (Fig. 1B, left), supporting the
notion that YY1 can potentially target these miRNAs, which leads
to transcriptional activation or inhibition. When the same method
was applied to MyoD, it was found that MyoD binding sites were
over-represented only in up-regulated miRNAs (Fig. 1B, right),
consistent with its accepted function as an activator in myogenesis.
Interestingly, using miRanda, a miRNA target prediction
program, we found that some YY1 regulated miRNAs could
potentially target YY1, thus forming negative feedback loops (data
not shown). This observation is in line with the belief that TF-
miRNA feedback loops commonly exist and provide more
coordinate and adaptable control for TF-miRNA circuitry to
regulate gene expression [29,30].
YY1 negatively regulates muscle miR expression during
myogenesis
Among all the putative YY1 target miRNAs, miR-1 and miR-
133 families are particularly attractive considering the pivotal roles
of these muscle miRs in regulating myogenesis [5]. We thus
examined the potential regulation of muscle miRs by YY1 in
C2C12. Total RNAs were collected from cells differentiated (DM)
for 0, 1, 3 or 5 days and used for measuring miR-1 and miR-133
expression levels. Consistent with others’ findings [15], both miR-1
and miR-133 were found to be robustly up-regulated during
C2C12 differentiation whereas YY1 expression was gradually
YY1-miR-1 Circuit in Skeletal Myogenesis
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primary myoblasts were isolated from hind limb muscles of
neonatal mice and grown in GM or differentiated in DM. As
shown in Fig. 2B, when induced to differentiation by serum
withdrawal, a sharp increase of both miR-1 and miR-133
expression was detected compared to GM cells. This up-regulation
was concomitant with the down-regulation of YY1 as well as the
induction of myogenic markers, Troponin, Myosin Heavy Chain
IIb (MyHC) and alpha Actin (a-Actin). To substantiate the above
results from cell culture studies, we extended the investigation to in
vivo muscles. The first model employed was postnatal muscle
development. In agreement with our previous findings [19], YY1
expression level decreased gradually as mice grow from 3 d to 5 w
old (Fig. 2C, left). As expected, both miR-1 and miR-133 levels
were up-regulated (Fig. 2C, middle and right), showing an inverse
relationship with YY1 expression. We then examined this
regulation in mdx muscles. As the commonly used mouse model
to study Duchenne muscular dystrophy, this mouse carries the
mutant dystrophin protein which leads to fiber necrosis, immune
cell infiltration and defected regeneration. Muscles from wild type
(WT) or mdx mice aging from 3 to 10 weeks were collected and
examined for miR-1 and 133 expressions by qRT-PCR. A
decrease of both miR-1 and 133 was detected in mdx muscles
compared to age-matched WT mice (Fig. 2D, left and middle).
However, YY1 expression level was found to be up-regulated at all
time points examined (Fig. 2D, right), indicating that the down-
regulation of miR-1 and miR-133 could be caused by elevated
YY1 levels. Collectively, our data from the above studies suggest
that YY1 negatively regulates miR-1 and miR-133 expression both
in physiological and pathological muscle conditions.
To further test the above notion, C2C12 myoblasts were
transfected with siRNA oligos knocking down YY1 (siYY1) or
negative control (siNC) oligos (Suppl. Fig. S1). By qRT-PCR assay,
both miR-1 and miR-133 levels increased over two folds upon
YY1 depletion (Fig. 2E), suggesting that there is a negative
regulation of miR-1 and miR-133 by YY1. When performed in
Table 1. Up-regulated miRNAs with predicted YY1 binding sites on promoter.
miRNA Fold Chang (DM/GM) P value Predicted No. of YY1 binding sites
mmu-miR-133b 73.53 ,10241
mmu-miR-133a-1 68.49 ,10241
mmu-miR-206 40.16 ,10241
mmu-miR-1-2 11.78 4610241
mmu-miR-196a-2 9.25 6610245
mmu-miR-192 9.44 7610246
mmu-miR-322 7.26 ,10242 0
mmu-miR-24-2 5.59 ,10242 1
mmu-miR-409 7.03 ,10244
mmu-miR-221 7.05 ,10243 3
mmu-miR-30e 4.31 0.01 4
mmu-miR-320 3.65 0.01 7
mmu-miR-9-3 3.52 0.01 21
mmu-miR-351 3.29 0.02 14
mmu-miR-199a-1 3.11 0.02 8
mmu-miR-380 3.04 0.02 4
mmu-miR-425 3.07 0.02 7
mmu-miR-130b 3.04 0.02 3
mmu-miR-145 3.03 0.03 12
mmu-miR-214 2.88 0.03 28
mmu-miR-138-2 2.86 0.03 1
mmu-miR-30a 2.66 0.03 3
mmu-miR-126 2.75 0.04 1
mmu-miR-200b 2.73 0.04 1
mmu-miR-15a 2.69 0.04 4
mmu-miR-153 2.71 0.04 1
mmu-miR-381 2.73 0.04 4
mmu-miR-130a 2.71 0.04 23
mmu-miR-154 2.69 0.04 4
mmu-miR-451 2.34 0.05 1
Genome-wide computational prediction reveals the prevalence of YY1 binding sites on promoters of miRNAs. C2C12 myoblasts were grown in growth
medium (GM) or differentiated in differentiation medium (DM) for 3 days. Total RNAs were extracted and subjected to expression profiling using a microarray platform.
77 miRNAs were found to be up-regulated in DM compared to GM with a fold change (DM/GM) more than 2. These miRNAs were run through the YY1 binding site
search pipeline. A total of 30 miRNAs were found to contain at least one YY1 binding site on their promoters.
doi:10.1371/journal.pone.0027596.t001
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significant increase of miR-1 and miR-133 (13.5 and 273 fold,
respectively) (Fig. 2F). To confirm that this regulation occurs
directly on transcriptional level, the level of primary transcripts
was assessed. The miR-1-2/miR-133a-1 cluster is transcribed
from a bicistronic miRNA precursor on the antisense strand of the
Mindbomb (Mib) gene on mouse chromosome 18 and the primary
transcript has been cloned [31]. Similar to mature miR-1 and
miR-133, the level of pri-miR-1/133 transcripts was found to be
induced upon siYY1 knockdown (Fig. 2G). The above findings
thus confirm the presence of a transcriptional repression of miR-1
and miR-133 by YY1.
Since YY1 is a transcriptional target of NF-kB [19], we
reasoned that miR-1 and miR-133 should also come under
negative control of NF-kB. Consistent with this thinking,
treatment of C2C12 myoblasts with TNFa as an activator of
NF-kB reduced miR-1 and miR-133 expression (Suppl. Fig. S2A).
Conversely, myoblasts expressing the IkBa-SR inhibitor of NF-kB
led to higher levels of miR-1/133 over that of control cells (Suppl.
Fig. S2B). These findings suggest that miR-1 and miR-133 are
subjected to regulation by NF-kB-YY1 signaling.
YY1 regulates muscle miRs through multiple enhancers
In order to further investigate the transcriptional regulatory
mechanisms of muscle miRs by YY1, we scrutinized their genomic
sequences for potential regulatory regions. Muscles miRs consti-
tute two distinct families, the miR-1 family (miR-1-1, miR-1-2,
and miR-206) and the miR-133 family (miR-133a-1, miR-133a-2,
and miR-133b). As mentioned earlier, miR-1-2/miR-133a-1
cluster is transcribed from a bicistronic miRNA precursor on the
antisense strand of Mib gene on mouse chromosome 18. Two
enhancers were identified based on genomic sequence conserva-
tion (Fig. 3A, E1 and E2). E1 is located approximately 2 kb
upstream of miR-1-2 while E2 is located in an intron separating
miR-1-2 and miR-133a-1 coding regions. It was demonstrated
that E2 is essential to direct miR-1-2/miR-133a-1 expression in
the somite myotomes and through the skeletal musculature in
embryogenesis [31]. A MEF2 site and a MyoD-binding E-Box are
required for the skeletal muscle expression of this enhancer. miR-
1-1/miR-133a-2 cluster is transcribed from non-coding regions on
mouse chromosome 2. A 4.3 kb muscle-specific enhancer
encompassing MEF2, MyoD and SRF binding sites, was
previously identified between miR-1-1 and miR-133a-2 coding
regions (Fig. 3B) [10,31]. When applied to miR-206/miR-133b
cluster of muscle miRs, a previously unknown enhancer was also
identified at 770 bp upstream of miR-206/miR-133b cluster
(Fig. 3C). And MyoD and myogenin occupancy have been
detected in this region by ChIP analyses [10].
Next, by using a scan for putative YY1 binding site,
CCATNTTN, using position weight matrices from TRANSFAC
database, we were able to identify a total of five conserved sites
with A and B located in E1 region, C in E2, D in E3 and E in E4
region (Fig. 3A–C), suggesting that these enhancer regions may
mediate YY1 repression on muscle miRs. To test this notion, we
cloned each enhancer region into the pGL3 luciferase reporter
vector. The resultant E1, E2, E3 or E4 luciferase reporter plasmids
were transfected into C2C12 cells along with an YY1 expression
plasmid (50, 200 or 500 ng). Results showed a dose-dependent
Figure 1. YY1 binding sites are enriched in both up- and down-regulated miRNAs. (A). miRNAs in DM cells are rank-ordered by the degree
of up-regulation (red) and down-regulation (green) relative to GM cells. (B). The two plots (left and right) show moving average of the frequency of
probes for genes that have YY1 or MyoD -binding sites in a 300-probe sliding window. The dashed line indicates the expected average (background
level or the ratio of the number of probes for YY1 or MyoD targets over the total number of interrogated gene probes).
doi:10.1371/journal.pone.0027596.g001
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PLoS ONE | www.plosone.org 4 February 2012 | Volume 7 | Issue 2 | e27596Figure 2. YY1 negatively regulates miR-1/133 expression both in vitro and in vivo. (A) C2C12 myoblasts were grown in growth medium
(GM) or differentiation medium (DM) for 2, 3 or 5 days. Total RNAs or proteins were extracted and used for real-time RT-PCR assay (left) or Western
blot analysis (right panel), respectively. (B) Primary myoblasts were isolated from limb muscles of 1 week old C57/BL6 mice and maintained in GM or
induced to differentiate in DM. Cell morphology was visualized under light microscopy (left). Real-time PCR was performed to measure the expression
levels of miR-1 and miR-133 normalized to U6 (middle). Semi-quantitative RT-PCR analysis was performed to measure the expression levels of
Troponin, MyHC, a-Actin and YY1. Water (H2O) was used as negative control and GAPDH was used as a normalization. (C) Total proteins were isolated
from lower limb muscles at post-natal day (P) 3 and 8 or tibialis anterior (TA) muscles from 2, 4, or 5 week old C57/BL6 background mice and Western
blotting was used to probe for YY1 protein expression with GAPDH as a loading control (left). Total RNAs were isolated and qRT-PCR was
subsequently performed to measure the expression of miR-1 and miR-133, normalized to U6 (middle and right). Expression folds are shown with
respect to 3 day old mice where miR-1 and miR-133 levels were set to a value of 1. (D) TA muscles were isolated from 3 w, 4 w, 5 w, 8 w and 10 w old
C57BL/6 wild type mice or mdx mice. RNAs were extracted and used for qRT-PCR assay of miR-1 (left), miR-133 (middle) or YY1 (right). Expression folds
YY1-miR-1 Circuit in Skeletal Myogenesis
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(Fig. 3D). Conversely, co-transfection of these reporters with
siYY1 oligos led to an increase of each reporter activity (Fig. 3E).
Consistent with previous reports, E1 reporter activity was
enhanced by MyoD and MEF2 over-expression (Suppl. Fig. S3).
These data suggest that YY1 functions to repress E1, E2, E3 and
E4 activities.
To test whether YY1 repression is mediated through the above
identified putative sites A to E, ChIP assay was performed against
YY1 using chromatins isolated from proliferating C2C12 myo-
blasts in GM or myotubes formed in DM. Primers were designed
to amplify regions encompassing sites A, B, C, D or E, respectively.
MyHC or Tnni2 promoter were known to be bound by YY1 in
myoblasts and used as positive controls. And a region with no YY1
site was used as negative control (NC). Results in Fig. 3F
demonstrated that a positive binding was detected on MyHC and
Tnni2 promoters in myoblasts and disappeared in myotubes as
previously shown [19]. Similarly, in myoblasts an association with
YY1 was found on sites A, B, D and the signal was lost or
diminished in myotubes, suggesting that these three sites are
competent for YY1 binding in myoblasts and YY1 is displaced
upon myogenic differentiation. On the other hand, no binding was
detected on sites C and E despite the fact that E2 and E4 are
responsive to YY1 modulation. It is likely that other YY1 binding
sites exist in these two regions and they are not predicted by the
computational algorithm under stringent criteria. Alternatively,
YY1 may be recruited to these regions indirectly through a co-
factor, bypassing the need for a YY1 binding site. To substantiate
the above ChIP data, we mutated site A in E1 Luciferase reporter
plasmid (Mut A). As expected, this mutation led to a slight rescue
of the repressed reporter activity by YY1 over-expression (Fig. 3G).
Further mutation of site B (Mut A+B), however, led to full rescue
of the inhibition by YY1, suggesting that sites A and B function
synergistically in mediating YY1 suppression. Taken together, the
above results suggest that sites A, B and D represent the binding
elements that mediate YY1 effect on E1and E3 regions. However,
since no positive binding was found on sites C and E, the true
binding sites await to be identified.
Since YY1 transcriptionally represses miR-29b/c through
recruitment of the Polycomb complex and the resultant trimethy-
lation of H3K27 [18], we asked whether similar regulation
occurred on muscle miRs loci. Indeed, in addition to YY1, we also
detected binding for Ezh2 and its trimethylated activity on H3K27
on sites A, B and D but not on C and E (Fig. 3H). And like YY1
binding, the association was lost in myotubes. Collectively, these
data suggest that YY1 regulates muscle miRs through recruitment
of the Polycomb complex to multiple enhancer regions similar to
its regulatory mode on miR-29b/c promoter.
YY1 regulates the pro-myogenic function of miR-1 during
C2C12 differentiation
Next, to address the functional significance of miR-1 regulation
by YY1, we assessed the effect of YY1 expression on the pro-
myogenic activity of miR-1 during C2C12 differentiation. C2C12
myoblasts were transfected with miR-1 oligos only or co-
transfected with miR-1 oligos and an YY1 expression plasmid.
Cells were then induced to differentiate for 2 days. The degree of
differentiation was assessed by examining the expression of MyHC
by immunofluroscence staining (Fig. 4A and 4B) or the expression
of a-Actin proteins by Western blotting (Fig. 4C). In agreement
with the known pro-myogenic function of miR-1, over-expression
of miR-1 (Lane 3: miR-1+Vector) accelerated the myogenic
program as shown by the significantly higher number of MyHC-
positive cells (Fig. 4A and 4B) and increased expression of a-Actin
(Fig. 4C) than that of control cells (Lane 1: NC+Vector). On the
contrary, YY1 over-expression (Lane 2: NC+YY1) inhibited
myogenic differentiation (Fig. 4A, 4B and 4C, Lane 2 compared
to Lane 1), which is in line with our previous findings
demonstrating YY1 as a repressor of myogenesis [18,19]. As
expected, YY1 over-expression on top of miR-1 (Lane 4: miR-
1+YY1) suppressed the pro-myogenic activity of miR-1 (Fig. 4A,
4B and 4C, Lane 4 compared to Lane 3). Results from analysis of
myogenic markers, MyHC, Troponin, a-Actin and Myogenin at
RNA levels were in agreement with the above findings (Fig. 4D).
Together, these data suggest that YY1 functions upstream of miR-
1 in regulating its pro-myogenic action.
YY1-miR-1-Pax 7 axis during myogenesis
The functions of miR-1 in muscle development and muscle
diseases have been the focus of intensive study. Deletion of miR-1-
2 in mice caused dysregulation of cardiogenesis [32]; miR-1 was
found to promote apoptosis of cardiomyocytes; recently, miR-1
was also demonstrated to exert a strong pro-myogenic influence on
poorly differentiated Rhabdomyosarcoma cells [33]; in skeletal
myogenesis, miR-1 is known to be pro-myogenic through targeting
histone deacetlylase 4 (HDAC4) [15]. Given that miRNAs are
known for their multi-targeting capability, we suspected that
additional targets may exist downstream of miR-1 and under
control of YY1-miR-1 axis. Interestingly, a search for putative
miR-1 targets by multiple algorithm (TargetScan, PicTar, and
miRanda) uncovered that Pax 7 could be a potential target with
two putative target sites identified at 1557 and 2100 bp of its
39UTR (Fig. 5A). To test whether miR-1 targets Pax7, a ,800 bp
fragment of Pax7 39UTR encompassing these two sites were
cloned into a pMIR-reporter vector. Co-transfection of the
resultant reporter plasmid together with miR-1 into C2C12 cells
caused a repression on luciferase activity (Fig. 5B), indicating that
miR-1 indeed directly targets Pax7. Furthermore, mutation of
either site A or site B restored the luciferease activity slightly but
mutations of both sites led to a full restoration, indicating that
these two sites may function synergistically (Fig. 5C). At the
functional level, we predicted that miR-1 binding to the Pax7
39UTR would lead to the repression on Pax7 expression.
Consistent with this prediction, transfection of miR-1 oligos
caused the decrease in both Pax7 mRNAs and proteins in addition
to inhibiting the previously characterized target, HDAC4 (Fig. 5D–
5E and Suppl. Fig. S4). In keeping with the above results, Pax7
expression level was down-regulated during the course of C2C12
differentiation concomitant to the gradual increase of miR-1
expression level (Fig. 5F). Furthermore, Pax7 was up-regulated in
YY1 over-expressed C2C12 cells and down-regulated in siYY1
knock-down cells compared to Vector or siNC controls, suggesting
are shown with respect to wild type where miR-1, miR-133 or YY1 levels were set to a value of 1. (E) C2C12 myoblasts or (F) primary myoblasts were
transfected with either negative control (siNC) or siRNA oligos against YY1 (siYY1). Cells were then cultured for 48 hours, at which time miR-1 and
miR-133 expressions were measured by qRT-PCR and normalized to U6. Expression folds are shown with respect to siNC where miR-1 and miR-133
levels were set to a value of 1. (G) Expression of the primary transcripts of miR-1-2/miR-133a-1 was detected by qRT-PCR in C2C12 transfected with
siYY1 or siNC oligos, and normalized to GAPDH. All quantitative data are represented as mean 6 S.D. The p value was determined by Student’s T-test:
*p,0.05, **p,0.01, ***p,0.001.
doi:10.1371/journal.pone.0027596.g002
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PLoS ONE | www.plosone.org 6 February 2012 | Volume 7 | Issue 2 | e27596Figure 3. YY1 repression of miR-1/133 is mediated through multiple enhancers. (A) Two conserved enhancers (E1 and E2) were identified
in the promoter region and intragenic region of miR-1-2/miR-133a-1 cluster, respectively. Three putative YY1 binding sites, A, B and C, were identified.
(B) One conserved enhancer (E3) was identified in between miR-1-1 and miR-133a-2 with a putative YY1 binding site, D, identified. (C) One conserved
enhancer (E4) was identified upstream of miR-206 and miR-133b cluster with a putative YY1 binding site, E, identified. Binding sites for MyoD, MEF2
and SRF were also shown. (D) C2C12 cells were transfected with 250 ng of E1, E2, E3 or E4 reporter plasmid along with Renilla and control vector (YY1
0 ng) or 50 ng, 200 ng, 500 ng YY1 expressing plasmid. Cells were then cultured for 48 h at which time luciferase activities were determined and
normalized to Renilla protein. The data represent the average of three independent experiments 6 S.D. (E) C2C12 cells were transfected with 0.25 mg
of E1, E2, E3 or E4 reporter plasmid along with Renilla luciferase vector and siYY1 or siNC oligos. Luciferase activity was determined as in (D). (F)
Chromatins were harvested from C2C12 myoblasts growing in growth medium (GM) or myotubes maintained in differentiation medium (DM) and
subjected to ChIP-PCR analysis. Primers were designed to amplify regions encompassing putative YY1 binding sites A, B, C, D, or E. MyHC and Tnni2
are known YY1 targets and used as positive controls. A genomic region that contains no YY1 binding sites was included as a negative control (NC). (G)
Site A (Mut A) or both A and B (Mut A+B) were mutated in E1 luciferase reporter plasmid and luciferase reporter assay was performed to measure the
YY1-miR-1 Circuit in Skeletal Myogenesis
PLoS ONE | www.plosone.org 7 February 2012 | Volume 7 | Issue 2 | e27596that Pax7 is under control by YY1-miR-1 signaling (Fig. 5G).
Taken together, these results implicate the existence of a functional
YY1-miR-1-Pax7 circuit during myoblast differentiation.
YY1 regulates miR-1 in cardiotoxin-induced muscle
regeneration
Lastly, to address whether the regulation of YY1 on muscle
miRs was relevant in vivo, we employed a Cardiotoxin (CTX)-
induced muscle injury model. After injection with CTX, TA
muscle displayed the typical degeneration-regeneration process:
fiber degeneration and immune cell infiltration were immediately
evident within 1 to 2 days; meanwhile, satellite cell started
proliferating followed by activation and myogenic differentiation 3
to 4 days afterwards; newly formed fibers with centrally located
nuclei were evident within 5 to 6 days; and muscle architecture
was largely restored within 10 days (Suppl. Fig. S5).
response of mutants to YY1 over-expression as in (D). Relative luciferase unit (RLU) is shown with respect to Vector transfection where luciferase
activities were set to a value of 1. (H) ChIP-PCR for Ezh2 or H3K27me3 was performed as in (F). The p value was determined by Student’s T-test:
*p,0.05, **p,0.01, ***p,0.001.
doi:10.1371/journal.pone.0027596.g003
Figure 4. YY1 represses miR-1 functionally during C2C12 myogenesis. (A) C2C12 cells were transfected with the indicated combination of
NC or miR-1 oligos and Vector or YY1 expression plasmids. Cells were then differentiated (DM) for 2 days, at which time cells were immunostained for
MyHC. Cell morphology was visualized by phase-contrast microscopy. (B) MyHC positive cells were quantified by counting positively stained cells
from 10 randomly chosen fields and are represented as mean 6 S.D. (C) Total proteins were isolated from the above transfected cells and Western
blotting was performed to probe for a-Actin. a-Tubulin was used as a loading control. (D) Total RNAs were extracted from the above transfected cells
and used for qRT-PCR analysis of myogenic markers, MyHC, Troponin, a-Actin, and Myogenin normalized with GAPDH. YY1 and miR-1 levels were also
measured to show the transfection efficiency. Quantitative values are represented as mean 6 S.D. The p value was determined by Student’s T-test:
*p,0.05, **p,0.01, ***p,0,001.
doi:10.1371/journal.pone.0027596.g004
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PLoS ONE | www.plosone.org 8 February 2012 | Volume 7 | Issue 2 | e27596Figure 5. miR-1 targets Pax7 during C2C12 differentiation. (A) Predicted target sites, A and B, of miR-1 in the 39UTR of mouse Pax7. (B) A
luciferase reporter plasmid was generated by cloning a ,800 bp region of Pax7 39UTR encompassing both site A and B downstream of the luciferase
(Luc) reporter gene. The reporter construct was then transfected into C2C12 cells with negative control (NC) or miR-1 oligos along with Renilla
luciferase plasmid. Luciferase activities were determined at 48 h post-transfection and normalized to Renilla readings. The data represent the average
of three independent experiments 6 S.D. (C) A mutation was introduced in either site A (Mut A) or site B (Mut B) or both (Mut A+B). Their responses
to miR-1 over-expression were tested as above. (D) C2C12 myoblasts were transfected with either NC or miR-1 oligos. Both miR-1 and Pax7 mRNAs
levels were then measured 48 hr post-transfection. (E) HDAC4 or Pax7 proteins were probed in extracts from cells 48 hr after transfection. Blots were
stripped and reprobed for a-Tubulin as the loading control. (F) Proteins extracted from C2C12 differentiated (DM) for 0 d, 1 d, 3 d and 5 d were used
for Western blotting assay of Pax7. a-Tubulin was used as a loading control. (G) Left: C2C12 myoblasts were transfected with Vector or YY1 expression
plasmid. Pax7 mRNA expression was then measured in extracts from cells 48 hr after transfection using GAPDH as normalization. Right: C2C12
myoblasts were transfected with siNC or siYY1 oligos. Pax7 mRNA expression was then measured in extracts from cells 48 hr after transfection using
GAPDH as normalization. Expression folds are shown with respect to Vector or siNC control where Pax7 levels were set to a value of 1. Values are
represented as mean 6 S.D. The p value was determined by Student’s T-test: *p,0.05, **p,0.01, ***p,0,001.
doi:10.1371/journal.pone.0027596.g005
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PLoS ONE | www.plosone.org 9 February 2012 | Volume 7 | Issue 2 | e27596Theexpression profilesofmiR-1 andmiR-133 wereexamined by
qRT-PCR analysis. As shown in Fig. 6A, for miR-1 expression, a
sharp decrease of ,5 fold in the first two days post-injury was
observed, after which its expression level gradually increased to ,2
fold of pre-injury level on day 6 but underwent a drop on day 9
during fiber maturation stage. The expression of miR-133 displayed
a similar change but the decrease in degeneration stage was much
stronger (,10 fold) and the elevation in regeneration stage was
lower compared to miR-1 level. This temporal expression pattern
suggests that a dynamic change of miR-1 and 133 expressions occur
during in vivo degeneration-regeneration process. The expression
level of YY1 was subsequently examined by Western blotting
analysis. To our expectation, it displayed an opposite trend as miR-
1/133 expression: a marked increase during first two days followed
by a decrease until day 6 and a bounce-back on day 9 (Fig. 6B). The
above data suggested that an inverse correlation exists between the
expression of miR-1/133 and YY1 during CTX-induced muscle
regeneration. To ascertain the functional significance of this
regulation, siYY1 or siNC oligos were injected into CTX-injured
TAmusclesfollowingtheadministrationschemeoutlinedinFig.6C.
Six hours after CTX injection into TA muscles, siNC or siYY1
oligos formulated with Lipofectamine 2000 were administrated into
left and right hind limbs, respectively. The injections were made
every two days for a total of three times. Muscles were collected at
day 2, 4 and 6 from treated muscles. Results from qRT-PCR
analysis (Fig. 6D) revealed that the expressions of miR-1 and miR-
133 were up-regulated in siYY1 injected muscles compared to siNC
injected muscles at all three time points (day 2, 4 and 6) during
muscle regeneration. A significant decrease of Pax 7 at both protein
(Fig. 6E) and RNA levels (Fig. 6F) was observed at all time points
examined, in support of the argument that Pax 7 is positively
regulated by YY1 mediated through miR-1. An evident decrease of
MyoD expression was also detected in siYY1 muscles compared to
siNC samples (Fig. 6E and 6F). The decrease of Pax7 and MyoD
implied that siYY1 knock-down may have inhibited satellite cell
proliferation and activation. However, a significant increase of
Myogenin expression was detected in siYY1 injected muscles
(Fig. 6E), indicating that the myogenic differentiation was
enhanced by siYY1 depletion. Given that a similar pro-myogenic
effect was observed when miR-1 oligos were administrated into
injured muscles [34], this suggests that YY1-miR-1 axis
represents a functional regulatory circuit during CTX induced
muscle regeneration.
A feedback regulation of YY1 by miR-1
Having gained insights into how YY1 regulates miR-1/133
family, we were intrigued to find out whether miR-1 can feedback
on YY1 to regulate its expression since this type of feedback
regulation is commonly existent between TFs and miRNAs.
Indeed, a miR-1 binding site was predicted on the 39 UTR of YY1
at 440 bp upstream of previously defined miR-29 binding site
(Fig. 7A). To test whether it mediates YY1 targeting by miR-1, a
reporter plasmid was generated by cloning this site into pMIR-
reporter vector. Co-transfection of the resultant reporter plasmid
with miR-1 oligos led to ,30% repression on luciferase activity
(Figure 7B). On the contrary, co-transfection of a negative control
(NC) or an irrelevant miR-518 oligo did not show any repression.
Furthermore, when the putative binding site was mutated, the
repression on reporter activity was abolished. At the functional
level, we predicted that miR-1 binding to the YY1 39UTR would
lead to repression of YY1 levels. Consistent with this prediction,
transfection of miR-1 oligos caused decrease on both YY1 mRNA
and protein levels (Fig. 7C). Collectively, our data support the
existence of a feedback regulation on miR-1 by YY1.
Discussion
This study was undertaken to investigate the potential interplay
between transcription factor and epigenetic modifier, YY1, and
miRNAs in skeletal myogenesis. Computational prediction of
YY1-miRNA interaction led to the identification of many
miRNAs as potential downstream targets of YY1. Subsequent
functional study validated the existence of a novel YY1-miR-1/
133 regulatory circuit during skeletal muscle differentiation both in
vitro in C2C12 cells and in vivo in a CTX induced muscle
regeneration model. Repression of muscle miR-1/133 family by
YY1 was mediated through three YY1 binding sites located in
multiple enhancer regions. Further investigation identified Pax7 as
a downstream target of miR-1 thus forming a functional YY1-
miR-1-Pax7 circuit which down-regulates Pax7 and promotes
myogenic differentiation (Fig. 8A). Moreover, we demonstrated
that YY1 is targeted by miR-1 through a negative feedback loop.
Therefore, the current studies, together with previous findings,
establish an YY1-centered functional network which integrates
both transcriptional and post-transcriptional regulatory circuitries.
As visualized by Cytoscape, miR-1, miR-133, miR-206 as well as
miR-29 are all under transcriptional repression by YY1. These
miRs, in turn, each down-regulates a set of protein coding genes at
post-transcriptional level, among which includes YY1 itself as
target of miR-1 and miR-29 (Fig. 8B).
The network of extensive regulatory interactions between
transcriptional factors (TFs) and post-transcriptional regulators
(miRs) is an interesting global feature and has been extensive focus
of study [29,30]. Our findings support the prevalence of reciprocal
regulation between YY1 and miRNAs, i.e. YY1 regulates miR and
the miR feeds-back on YY1. This kind of multi-level combinatorial
interactions can ensure a gene to be tuned at a level of precision
that is higher than what may be obtained by either mechanism
alone.
Our findings also underscore the importance of YY1 as a
chromatin modifier in skeletal myogenesis. Although emerging
evidences implicate the inter-connection of miRNAs and the
epigenetic machinery especially in various cancers [35,36], studies
of miRNA-epigenetics interplay is still scarce in the skeletal muscle
research field [37]. Our findings support the notion that
miRNome-epigenome interplay is a prevalent mechanism in
skeletal muscle and also highlight the importance of histone-
associated epigenetic control of muscle gene expression.
Despite increasing amounts of reports on the number of
miRNAs involved in myogenesis, miR-1 and 133 families remain
on the center stage [5]. The functional characterization of these
muscle miRs has been critical in our understanding of miRNA-
mediated muscle development. An intriguing feature of their
function is their opposing roles in regulating myogenic differen-
tiation. miR-1 is shown to promote myoblast differentiation while
miR-133 promotes myoblast proliferation and inhibits myogenic
differentiation [15]. The rapid induction of miR-133 during
differentiation and its high expression level in muscle tissue seems
to contradict its documented role as growth-stimulatory and anti-
myogenic. We noticed that the level of miR-1 rose faster during
both C2C12 myoblast differentiation and CTX induced muscle
regeneration, leading us to speculate that the predominant
increase in miR-1 overweighs that in miR-133, favoring the
progression of myogenic differentiation. Our view is consistent
with a recent report demonstrating that miR-1 and miR-133
produced opposing effects on apoptosis in cardiomyocytes despite
the similar regulation [38]. It also indicates that it is critical to
consider the combinatorial effects of miRs when interpreting their
downstream output.
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PLoS ONE | www.plosone.org 10 February 2012 | Volume 7 | Issue 2 | e27596Figure 6. YY1 negatively regulates miR-1 during CTX-induced muscle regeneration. (A)Tibialisanterior(TA)musclesfromsix-weekoldC57/
BL6 background mice were injected with 10 mM cardiotoxin (CTX). RNAs and proteins were then extracted from injected muscles at the indicated days
post-injection, andqRT-PCRwas performed to measure the expression of miR-1 andmiR-133, normalized to U6. Expressionfolds areshownwith respect
to day 0 where miR-1 and miR-133 levels were set to a value of 1. Quantitative values are represented as means 6 S.D. (B) YY1 expression was measured
by Western blotting. a-Tubulin was used as a loading control. Numbers below indicates the quantification by densitometry. (C) TA muscles from 6 week
C57/BL6 background mice were injectedCTXat day0,followed byinjectionwith siNC (left leg) andsiYY1 oligos(rightleg) 6 hours later. And re-injection
of siRNA oligos was performed every other day for two more times. The injected muscles were harvested at the indicated days. N=6 for each group. (D)
Expressions of miR-1 and miR-133 were detected by qRT-PCR in CTX/siRNA injected muscles at day 2, 4 and 6, normalized to U6. Expression folds are
shown with respect to siNC where miR-1 and miR-133 levels were set to a value of 1. (E) Western blotting was performed to analyze the expression of
YY1, Pax7, MyoD and Myogenin. a-Tubulin was used as a loading control. Data is representative of 6 mice. (F) Expression of Pax7 and MyoD RNA levels
were also detected by qRT-PCR normalized with GAPDH. Expression folds are shown with respect to siNC where Pax7 and MyoD levels were set to a
value of 1. Quantitative values are represented as mean 6 S.D. The p value was determined by Student’s T-test: *p,0.05, **p,0.01, ***p,0,001.
doi:10.1371/journal.pone.0027596.g006
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PLoS ONE | www.plosone.org 11 February 2012 | Volume 7 | Issue 2 | e27596Although miR-1 and miR-133 are clustered on the same
chromosomal loci and transcribed together as a single transcript,
there seems to be a stronger regulation on miR-133 by YY1 than
on miR-1 as depleting YY1 increased miR-133 to a much higher
levels than that of miR-1 (Fig. 2F) and over-expressing YY1 also
down-regulated miR-133 more than miR-1 (data not shown). We
reasoned there may be two possibilities: first, it may be attributed
to the fact that three copies of miR-133 are under regulation by
YY1 whereas only two copies of miR-1 are subjected to YY1
regulation (Fig. 3A–C). Second, in addition to regulating the
transcription of primary miR-1/133 transcripts, YY1 may also
exert regulation at a later stage of miR-1/133 biogenesis, resulting
in different rates of miR-1 and miR-133 production. Thus, the
regulation by YY1 may exert a master control of the ratio of miR-
1 and 133 which is critical for their net effect on myogenesis. It
should be noted that our study only provided indirect evidence for
the above notion and more rigorous experimentation is required to
test our hypothesis. In addition, our studies focused on the
regulation of YY1 on miR-1 and its downstream event; it will be
interesting to explore how YY1 regulated miR-133 affect satellite
cell proliferation and differentiation processes.
In this study, we identified two new targets of miR-1, Pax7 and
YY1, in addition to the previously known HDAC4. During the
preparation of this manuscript, Chen et al recently demonstrated
that miR-1 and miR-206 regulate skeletal muscle satellite cell
proliferation and differentiation by repressing Pax7 using primary
satellite cell culture [39]. Our results from using C2C12 cells
reinforced the view that Pax7 is crucial for satellite cell
proliferation and needs to be down-regulated for the cells to
transit into myogenic differentiation. The YY1-miR-1-Pax7 axis
represents an important circuit that regulates transition from
proliferation to differentiation. In addition to its anti-differentia-
tion function, YY1, through its regulation on miR-1-Pax7, may
play a crucial role in regulating satellite cell proliferation. Indeed,
YY1 expression has sharply increased after CTX injury (Fig. 6).
And knocking-down of YY1 down-regulated Pax7 in CTX injured
muscles. Our results, thus, reinforce the idea that miRNA exerts
their function through multiple targets to provide robust
regulation during myogenic differentiation.
Others and our findings suggest that miR-1 not only functions
during myogenic differentiation but also participates in satellite
cell activation, proliferation and possibly self-renewal. In addition,
Figure 7. miR-1 inhibits YY1 expression through targeting its 39UTR. (A) Predicted target site of miR-1 in the 39UTR of mouse YY1. (B) A wild
type (WT) luciferase reporter plasmid was generated by fusing a ,500 bp fragment of the YY1 39UTR encompassing the miR-1 binding site
downstream of the luciferase (Luc) reporter gene. The mutant plasmid was generated by mutating the miR-1 binding site from ACAUUCU to
GGGCCUU. WT or Mutant reporter construct was transfected into C2C12 cells with indicated miRNA oligos and Renilla luciferase reporter plasmid.
Luciferase activities were determined at 48 h post-transfection and normalized to Renilla readings. Relative Luciferase Unit (RLU) is shown with
respect to wild type and NC transfection where luciferase activities were set to a value of 1. The data represent the average of three independent
experiments 6 S.D. (C) Upper: C2C12 myoblasts were transfected with either NC or miR-1 oligos. Total RNAs were used to detect YY1 expression level
with GAPDH as normalization. Expression folds are shown with respect to negative control where YY1 levels were set to a value of 1. Quantitative
values are represented as mean 6 S.D. Lower: YY1 protein was then probed in extracts from cells 48 hr after transfection. Blots were stripped and
reprobed for a-Tubulin as the loading control. The p value was determined by Student’s T-test: *p,0.05, **p,0.01, ***p,0.001.
doi:10.1371/journal.pone.0027596.g007
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PLoS ONE | www.plosone.org 12 February 2012 | Volume 7 | Issue 2 | e27596Figure 8. A model of NF-kB-YY1-miR-1-Pax7 circuit in skeletal myogenesis. The model depicts the role of the NF-kB-YY1-miR-1 regulatory
circuit in myogenic differentiation. This circuit involves the constitutive activity of NF-kB in myoblasts that regulates YY1 expression which
subsequently suppresses miR-1 expression epigenetically and maintains cells in an undifferentiated state. As differentiation is initiated, the down-
regulation of the NF-kB-YY1 pathway leads to concomitant up-regulation of miR-1 that in turns further decreases YY1 as well as Pax7 levels to ensure
proper differentiation into myotubes. (B) Network visualization depicting YY1-centered circuitry drawn by Cytoscape. Findings from the current
studies demonstrate a repression of miR-1, miR-133 and miR-206 by YY1. Together with previous findings, these interactions constitute an YY1-
miRNA regulatory network. YY1, Yellow octagon; miRNAs, red diamonds; Experimentally validated miRNA targets, grey circles; red blunted arrows,
transcriptional repression; black blunted arrows, post-transcriptional repression.
doi:10.1371/journal.pone.0027596.g008
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PLoS ONE | www.plosone.org 13 February 2012 | Volume 7 | Issue 2 | e27596Nakasa T. also showed that administration of miR-1 together with
133 and 206 into injured muscles reduced fibrosis [34], suggesting
a role for miR-1 in anti-fibrotic event with unknown mechanism.
It will be interesting to dissect the downstream regulatory targets
mediating these functions of miR-1 and to elucidate the
significance of YY1-miR-1 regulation in various events.
Finally, other than miR-1 and 133 families, a number of
miRNAs could be regulated by YY1 according to our results
(Table 1 and Suppl. Table S2), strengthening the idea that
regulatory circuitry involving miRNAs and TFs are prevalent
mechanisms of gene expression. Characterization of their interplay
with YY1 and downstream targets will enhance our understanding
on the global architecture of the combined transcriptional/post-
transcriptional regulatory network. In addition, our current studies
demonstrated that bioinformatics pipeline combining computa-
tional prediction with expression data can be a powerful tool for
constructing TF-miRNA regulatory network, particularly for those
TFs on which the genome-wide mapped targets by experimental
methods such as ChIP coupled with high throughput sequencing
(ChIP-seq) are not available yet. This kind of network analysis will
provide insights into biological systems that cannot be obtained in
single TF or miRNA studies.
Materials and Methods
Cell
Mouse C2C12 myoblasts were obtained from ATCC and
cultured in DMEM supplemented with 10% FBS, 2 mM L-
glutamine, 100 U/ml penicillin, and 100 mg of Streptomycin at
37uCi n5 %C O 2. For myogenic differentiation experiments, cells
were seeded in 60 mm or 100 mm plates and when 90% confluent
they were shifted to DMEM without FBS containing 2% horse
serum.
Primary myoblast isolation and culture
Primary myoblasts were isolated from approximately one week
old C57/BL6 muscles as previously described. Briefly, total hind
limb muscles (3 to 6 mice per group) were digested with type IV
collagenase (Invitrogen, 5 mg/ml) and dispase II (Invitrogen,
1.4 mg/ml) for 0.5 hr, and cell suspensions were filtered through
40 mM and 70 mM filters and then pre-plated for an hour. Non-
adherent cells were centrifuged and cultured on Gelatin-coated
plates (Iwaki) in F10 medium (Invitrogen) supplemented with 20%
FBS and Basic Fibroblast Growth Factor (Invitrogen, 25 ng/ml).
After removing most fibroblast by pre-plating, primary myoblast
cells are cultured in F10/DMEM medium supplemented with
20% FBS and Basic Fibroblast Growth Factor (Invitrogen).
Transfection and infection
Transient transfection with miRNA precursor oligos or siRNA
oligos was performed in 60 mm or 100 mm dishes with
Lipofectamine 2000 as suggested by the manufacturer (Invitrogen).
For luciferase experiments, C2C12 and primary mouse skeletal
muscle myoblasts were transfected in 12-well plates. Cell extracts
were prepared and luciferase activity was monitored using Dual
Luciferase kit (Promega, E1910).
Oligonucleotides
Precursor miRNA oligos were obtained from Ambion. siRNA
oligos against mouse YY1 were obtained from Santa Cruz
technologies. In each case 50 mM oligos were used for transient
transfections. The sequences of oligonucleotides used for RT-
PCR, ChIP-PCR and cloning are included in Supplemental
Material (Suppl. table S5).
DNA constructs
To construct E1, E2 and E4 luciferase reporter plasmids, the
enhancer fragments E1: chr18:10,787,547–10,788,045 (486 bp), E2:
chr18:10,784,080–10,784,701 (622 bp), or E4: chr1:20,667,759–
20,668,359 (600 bp), were PCR amplified from mouse genomic
DNA and cloned between a Kpn1 and Nhe1 site of a PGL2 vector
(Promega),upstream of the luciferase gene;E3luciferase reporter was
generated as above by cloning 1150 bp (chr2:180,129,142–
180,130,290) of PCR fragment between Kpn1 and Xho1 site of
PGL2 vector. Mutant reporter plasmids were generated by deleting
YY1 binding site A or mutating binding site B from ATGG to
GTCC. YY1 expression plasmidandYY1-39UTR luciferasereporter
plasmid were described before (Wang et al., 2008). A mutant YY1-
39UTR plasmid was generated by changing miR-1 binding site from
ACATTC to GGGCCT. To construct Pax7-39UTR reporter
plasmid, an 805 bp (chr4:139,294,480–139,295,283) fragment en-
compassing binding site A and site B was cloned into pMIR-report
vector (ABI) between SpeI and HindIII sites. The mutant Pax7-
39UTR plasmids were generated by deleting each of the miR-1
binding seed region ACATTCC.
RT-PCR and Real-time RT-PCR
Total RNAs from cells were extracted using TRIzol reagent
(Invitrogen). Expression of mature miRNAs was determined using
the miRNA-specific Taqman microRNA assay kit (Applied
Biosystem) in a 7900HT system (Applied Biosystem). U6 was
used for normalization. Expression of mRNA analysis was
performed as described using GAPDH for normalization [19].
Immunoblotting and Immunostaining
Total cell extracts were prepared and used for analysis of
protein expression as previously described [19]. The following
dilutions were used for each antibody: YY1 (mouse monoclonal
from Santa Cruz Biotechnology, Cat# SC-7341; 1:1000), MyHC
(mouse monoclonal from Sigma, Cat# M4276; 1:1,000), HDA-
C4(rabbit polyclonal from Santa Cruz Biotechnology, Cat# SC-
11418; 1:1000), Pax7 (mouse monoclonal from DSHB, 1:1000), a-
Actin (goat polyclonal from Santa Cruz Biotechnology, Cat# SC-
1615; 1:1000), Troponin (mouse monoclonal from Sigma, Cat#
T6277; 1:1000), MyoD (rabbit polyclonal from Santa Cruz
Biotechnology, Cat# SC-760; 1:1000), Myogenin (rabbit poly-
clonal from Santa Cruz Biotechnology, Cat# SC-576; 1:1000), a-
Tubulin (mouse monoclonal from Sigma, Cat# T5168; 1:5000),
GAPDH (mouse monoclonal from Santa Cruz Biotechnology,
Cat# SC-137179; 1:5000). Immunofluorescence of C2C12 cells
was performed using a MyHC monoclonal antibody (mouse
monoclonal from Sigma, Cat# M4276) at 1:500 dilution.
ChIP assays
ChIP assays were performed as previously described (Tong Ihn
Lee, 2006) using 5 mg of antibodies against YY1 (rabbit polyclonal
from Santa Cruz Biotechnology, Cat# SC-1703), Ezh2 (mouse
monoclonal from Cell Signaling, Cat# AC22), trimethyl-histone
H3-K27 (rabbit polyclonal from Milipore, Cat# 07-449), or
without any antibody as a negative control. Genomic DNA pellets
were resuspended in 10 ml of water. PCR was performed with 1 ml
of immunoprecipitated material and products were analyzed on an
agarose gel visualized by a GelDoc documentation system (Bio-
Rad Laboratories).
Animal studies
Mice used in this study were housed in the animal facilities of
the Chinese University of Hong Kong under conventional
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standard diet. Animal experimentation was approved by the
CUHK Animal Experimentation Ethics Committee (Ref No. 10/
027/MIS). Postnatal muscles were obtained from C57/BL6 mice,
and RNAs were extracted for real-time RT-PCR analysis. For
Cardiotoxin studies, approximately six-week old C57/BL6 mice
were injected with 60 ml of Cardiotoxin at 10 mg/ml into the
tibialis anterior muscle. Muscles were harvested at designated
times, and RNAs were extracted for real-time RT-PCR analysis,
and proteins were extracted for Western analysis. Injections of
siRNA oligos were performed six hours after Cardiotoxin injection
and re-injected every two days for a total of three times. Oligos
were prepared by pre-incubating 5 mM of siRNA oligos with
Lipofectamine 2000 for 15 minutes and injections were made in a
final volume of 60 ml in OPTI-EM (GIBCO). Mdx (C57BL/10
ScSn DMDmdx) mice were purchased from the Jackson
Laboratory. Mice were housed in the animal facilities of the
Chinese University of Hong Kong under conventional conditions
with constant temperature and humidity and fed a standard diet.
Animal experimentation was approved by the CUHK Animal
Ethics Committee.
Computational prediction pipeline for TF binding sites
identification
miRNA promoter annotation was retrieved from Marson et al
[22]. A promoter prediction program EP3 [23] was used to further
refine the miRNA promoter regions using 200 bp window. The
refined promoter regions were extended by 15 kbp on both sides
and subjected to YY1 binding sites search. In order to predict YY1
binding sites, four YY1 position weight matrices (PWMs) were
retrieved from Transfac database [24] and used to scan the
promoter regions defined above using STORM program [25] by
selecting the top 500 YY1 binding sites among all the predictions.
Prediction of miRNA target was performed using three publicly
available algorithms: TargetScan (http://www.targetscan.org/),
miRanda (http://www.microrna.org/) and PicTar (http://pictar.
bio.nyu.edu/). Network visualization was carried out using
Cytoscape. (http://cytoscapeweb.cytoscape.org/).
miRNA gene expression by microarray
RNAs were extracted from C2C12 myoblasts or myotubes by
Trizol and used for genome-wide miRNA profiling using a
microarray platform developed by the Ohio State University, USA
(microRNACHIPv4, http://www.osuccc.osu.edu/microarray/).
Each time point was represented by two biological replicates.
For each sample, 1 mg of total RNAs were labeled and hybridized
to the microarray. Microarrays were scanned on Axon 4000B
Scanner (Molecular Devices). Data were subsequently analyzed
by a software package limma [40,41] from R for array
normalization. After normalization, the miRNA probes were
ranked by RankProd [42] based on their normalized intensity.
The heatmap of the ranked miRNA probes was generated using
Java Treeview [43]. All microarray data presented in this
manuscript are in accordance with Minimum Information About
a Microarray Experiment (MIAME) guidelines and have been
deposited in the National Center for Biotechnology Information
(NCBI) GEO data base (accession number: GSE32238). In order
to visualize if YY1 target miRNA genes are enriched in the
differentially expressed miRNAs, the frequency of miRNA probes
belonging to the miRNA genes that predicted as YY1 targets was
calculated within each 300-probe sliding window with 1 probe
increment each time from the probe sets that are ranked by
RankProd.
Statistical analysis
Data were represented as means6 standard deviation (S.D.).
Statistical significance between two groups was determined by
Student’s t test. A P value of less than 0.05 was considered
statistically significant.
Supporting Information
Figure S1 YY1 was successfully knocked down by siRNA
oligos in C2C12 cells. C2C12 myoblasts were transfected with
50 nM of negative control (siNC) or YY1 siRNA (siYY1) oligos.
48 hr post-transfection, cells were collected for Western blotting
analysis of YY1 protein expression using an YY1 antibody. a-
Tubulin was used as a loading control.
(PDF)
Figure S2 NFkB suppresses miR-1 and miR-133 expres-
sion through YY1. (A) C2C12 cells were treated with 10 ng/ml
of TNFa. miR-1 and miR-133 expression was then measured by
qRT-PCR normalized to U6. Expression folds are shown with
respect to TNF treated cells where miR-1 or miR-133 levels were
set to a value of 1. (B) Expression of miR-1 and miR-133 was
measured in C2C12 myoblasts stably expressing Vector or the
IkBa-SR transgene. Expression folds are shown with respect to
vector cells, which were set to a value of 1. Quantitative values are
represented as mean 6 S.D.
(PDF)
Figure S3 Activation of E1 luciferase reporter by MyoD
and MEF2. (A and B) C2C12 cells were transfected with MyoD
or MEF expressing plasmids along with E1 luciferase reporter
plasmid and Renilla reporter plasmid. Luciferase activities were
determined at 48 h post-transfection and normalized to Renilla
readings. The data represent the average of three independent
experiments 6 S.D.
(PDF)
Figure S4 Pax7 protein is down-regulated by miR-1
over-expression. C2C12 myoblasts were transfected with either
NC or miR-1 oligos. Pax7 proteins were probed in extracts from
cells 48 hr after transfection. Blots were stripped and reprobed for
GAPDH as the loading control.
(PDF)
Figure S5 CTX induced muscle degeneration and
regeneration. Cardiotoxin was injected into Tibialis anterior
muscles of C57/BL6 mice. Muscles were harvested at designated
times. H&E staining was performed on cryosections of muscles.
(PDF)
Table S1 Predicted promoter regions for mouse miRNA
genes. The promoter score was extracted from Marson et al. [22].
Four YY1 positional weight matrices from Transfac database,
YY1_01, YY1_02, YY1_Q6, and YY1_Q6_02, were used to scan
for YY1 binding motif on miRNA promoters. The motif score was
calculate by Storm [25]. Relative motif position refers to the
distance to promoter start position.
(PDF)
Table S2 Up-regulated miRNAs during myoblasts dif-
ferentiation into myotubes as revealed by miRNA
microarray profiling. C2C12 myoblasts were grown in growth
medium (GM) or differentiated in differentiation medium (DM) for
1 or 3 days. Total RNAs were extracted and subjected to expression
profiling using a microarray platform. A total of 77 miRNAs were
found to be up-regulated in DM 3 d as compared to GM.
(PDF)
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differentiation into myotubes as revealed by miRNA
microarray profiling. A total of 68 miRNAs were found to be
down-regulated with a fold change more than 2.
(PDF)
Table S4 Computational prediction reveals the preva-
lence of YY1 binding sites on promoters of down-
regulated miRNAs. The 68 down-regulated miRNAs were
run through the YY1 binding site search pipeline. A total of 27
miRNAs were found to contain at least one YY1 binding site on
their promoters.
(PDF)
Table S5 Oligonucleotides used for RT-PCR, ChIP-PCR
and cloning.
(PDF)
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